BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20801538)

  • 1. The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.
    Hanoun N; Bureau C; Diab T; Gayet O; Dusetti N; Selves J; Vinel JP; Buscail L; Cordelier P; Torrisani J
    J Hepatol; 2010 Nov; 53(5):880-8. PubMed ID: 20801538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
    Yea S; Narla G; Zhao X; Garg R; Tal-Kremer S; Hod E; Villanueva A; Loke J; Tarocchi M; Akita K; Shirasawa S; Sasazuki T; Martignetti JA; Llovet JM; Friedman SL
    Gastroenterology; 2008 May; 134(5):1521-31. PubMed ID: 18471523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
    Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
    Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of KLF6-SV2 in colorectal cancer and its impact on proliferation and apoptosis.
    Zhang B; Guo DD; Zheng JY; Wu YA
    Eur J Cancer Prev; 2018 Jan; 27(1):20-26. PubMed ID: 29084019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
    Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
    Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New candidate tumor-suppressor gene KLF6 and its splice variant KLF6 SV2 counterbalancing expression in primary hepatocarcinoma.
    Zhenzhen Z; De'an T; Limin X; Wei Y; Min L
    Hepatogastroenterology; 2012; 59(114):473-6. PubMed ID: 21940380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of KLF6 and its splice variant KLF6V on proliferation and differentiation of human hepatocellular carcinoma HepG2 cells].
    Pan XC; Chen Z; Ji F; Guo ZS; Chen M; Fu JJ
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):683-7. PubMed ID: 18822210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo regulation of p21 by the Kruppel-like factor 6 tumor-suppressor gene in mouse liver and human hepatocellular carcinoma.
    Narla G; Kremer-Tal S; Matsumoto N; Zhao X; Yao S; Kelley K; Tarocchi M; Friedman SL
    Oncogene; 2007 Jun; 26(30):4428-34. PubMed ID: 17297474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
    Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
    J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent down-regulation and deletion of KLF6 in primary hepatocellular carcinoma.
    Wang S; Kang L; Chen X; Zhou H
    J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):470-6. PubMed ID: 20714872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines.
    Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J
    J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mutations of the tumor suppressor Kruppel-like factor 6 (KLF6) gene in hepatocellular carcinoma and its effect of growth suppression on human hepatocellular carcinoma cell line HepG2].
    Pan XC; Chen Z; Chen F; Chen XH; Zhou C; Yang ZG
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):109-13. PubMed ID: 16494780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced hepatocarcinogenesis in mouse models and human hepatocellular carcinoma by coordinate KLF6 depletion and increased messenger RNA splicing.
    Vetter D; Cohen-Naftaly M; Villanueva A; Lee YA; Kocabayoglu P; Hannivoort R; Narla G; M Llovet J; Thung SN; Friedman SL
    Hepatology; 2012 Oct; 56(4):1361-70. PubMed ID: 22535637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibitory effect of Krüppel-like factor 6 on human prostatic carcinoma and renal carcinoma cell lines.
    Cheng XF; Li D; Zhuang M; Chen ZY; Lu DX; Hattori T
    Tohoku J Exp Med; 2008 Sep; 216(1):35-45. PubMed ID: 18719336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of miRNAs that specifically target tumor suppressive KLF6-FL rather than oncogenic KLF6-SV1 isoform.
    Liang WC; Wang Y; Xiao LJ; Wang YB; Fu WM; Wang WM; Jiang HQ; Qi W; Wan DC; Zhang JF; Waye MM
    RNA Biol; 2014; 11(7):845-54. PubMed ID: 24921656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk.
    Narla G; Difeo A; Reeves HL; Schaid DJ; Hirshfeld J; Hod E; Katz A; Isaacs WB; Hebbring S; Komiya A; McDonnell SK; Wiley KE; Jacobsen SJ; Isaacs SD; Walsh PC; Zheng SL; Chang BL; Friedrichsen DM; Stanford JL; Ostrander EA; Chinnaiyan AM; Rubin MA; Xu J; Thibodeau SN; Friedman SL; Martignetti JA
    Cancer Res; 2005 Feb; 65(4):1213-22. PubMed ID: 15735005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation.
    Kremer-Tal S; Narla G; Chen Y; Hod E; DiFeo A; Yea S; Lee JS; Schwartz M; Thung SN; Fiel IM; Banck M; Zimran E; Thorgeirsson SS; Mazzaferro V; Bruix J; Martignetti JA; Llovet JM; Friedman SL
    J Hepatol; 2007 Apr; 46(4):645-54. PubMed ID: 17196295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small interfering RNA targeting the KLF6 splice variant, KLF6-SV1, as gene therapy for gastric cancer.
    Chen H; Chen L; Sun L; Zhen H; Li X; Zhang Q
    Gastric Cancer; 2011 Oct; 14(4):339-52. PubMed ID: 21538018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of KLF6 and its splice variants in cancer therapy.
    DiFeo A; Martignetti JA; Narla G
    Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress modulates KLF6Full and its splice variants.
    Urtasun R; Cubero FJ; Nieto N
    Alcohol Clin Exp Res; 2012 Nov; 36(11):1851-62. PubMed ID: 22486562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.